Month: May 2020

Eufoton® is a leading Italian manufacturer specialized in developing and producing portable medical lasers. The company was founded in 1999 by a highly-skilled medical and engineering team. Today, Eufoton®’s diode lasers are successfully used in many medical specialities. One of the most sought-after treatment patented by Eufoton® is ENDOLIFT®, a minimally invasive outpatient laser procedure used in endo-tissutal (interstitial) aesthetic medicine. The laser treatment is performed with the latest Eufoton® LASEmaR® 1500 (certified and approved by the American FDA for laser assisted liposuction).…

Researchers at the Max Planck Institute for Intelligent Systems in Germany have developed powerful nanopropellers that can be steered into the interior of cells to deliver gene therapy. The magnets that these devices, each about the size of a bacteria, are made of were created for the first time for this very task. Most powerful magnets are either not bio-compatible, lose their properties at small scales, or cannot be manufactured to have very fine details, so cannot be used to…

Aspenstate announced that it has received FDA clearance for the AiRTouch, a lightweight portable X-ray system that could be particularly useful for quickly obtaining chest X-rays of COVID-19 patients. The handheld device weighs in at 5.5 pounds (2.5 Kg) and resembles a large digital camera with a touchscreen. AiRTouch acquires images with the push of a button and can wirelessly transmit them to PACS (clinical image storage system), without the need for a computer. Its battery charges within two hours and…

LifeSignals, recently made an announcement that it received the CE Mark for its LifeSignals ECG Remote Monitoring Patch. The patch, integrated with a remote monitoring platform, is designed as continuous electrocardiography (ECG) and heart rate monitor. The ECG Remote Monitoring Patch is disposable and captures data for up to three days. The device is lightweight and splash-proof. Each patch features the company’s patented LC1100 Life Signal Processor, which operates on a coin-cell battery and detects, stores, and securely transmits patient…

VitalConnect announced that it has received FDA Emergency Use Authorization status for use of its VitalPatch to detect changes in the QT interval of hospitalized patients undergoing drug treatment for COVID-19. Hydroxychloroquine and chloroquine, used to treat some COVID-19 patients, are associated with risk of prolonged QT interval that can lead to life-threatening arrhythmias. VitalPatch allows clinicians to remotely and continuously monitor patients at risk of QT prolongation due to COVID-19 treatment. VitalPatch is an FDA-approved device. Besides serving as a…